Abiopharma

New Form 424B2 - UBS AG <b>Filed:</b> 2026-05-12 <b>AccNo:</b> 0001839882-26-023718 <b>Size:</b> 554 KB

Director Norton Nancy A 🟢 acquired 2.3K shares (1 derivative) of Leidos Holdings, Inc. (LDOS) at $131.26 Transaction Date: May 08, 2026 | Filing ID: 000208

(30% Negative) TON STRATEGY CO (TONX) Reports Q2 2026 Financial Results

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-05-12 <b>AccNo:</b> 0001918704-26-012739 <b>Size:</b> 840 KB

Virtuix Expands Global Rollout of Omni One with Canada Launch Amid Rising Demand for Immersive Gaming and Fitness

Starbar® Unveils Bold Rebrand, Expanding Product Line for Rural and Backyard Use

Director Shanahan Patrick M 🟢 acquired 2.3K shares (1 derivative) of Leidos Holdings, Inc. (LDOS) at $131.26 Transaction Date: May 08, 2026 | Filing ID: 000207

New Form SCHEDULE 13G - REGENXBIO Inc. <b>Filed:</b> 2026-05-12 <b>AccNo:</b> 0000093751-26-000286 <b>Size:</b> 8 KB

Director SHAPARD ROBERT S 🟢 acquired 2.3K shares (1 derivative) of Leidos Holdings, Inc. (LDOS) at $131.26 Transaction Date: May 08, 2026 | Filing ID: 000206

New Form 424B2 - ROYAL BANK OF CANADA <b>Filed:</b> 2026-05-12 <b>AccNo:</b> 0000950103-26-007083 <b>Size:</b> 510 KB

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-05-12 <b>AccNo:</b> 0001918704-26-012738 <b>Size:</b> 664 KB

New Form SCHEDULE 13G - RECURSION PHARMACEUTICALS, INC. <b>Filed:</b> 2026-05-12 <b>AccNo:</b> 0000093751-26-000285 <b>Size:</b> 8 KB

New Form SCHEDULE 13G - Ramaco Resources, Inc. <b>Filed:</b> 2026-05-12 <b>AccNo:</b> 0000093751-26-000284 <b>Size:</b> 8 KB

OPKO Health’s ModeX Therapeutics Will Present Data Demonstrating In Vivo CAR-T Cell Generation and Deep B-Cell Depletion in Preclinical Studies

New Form SCHEDULE 13G - Protagonist Therapeutics, Inc <b>Filed:</b> 2026-05-12 <b>AccNo:</b> 0000093751-26-000283 <b>Size:</b> 8 KB